Enovis Retained Earnings (Accumulated Deficit) 2010-2024 | ENOV
Enovis retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Enovis Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $542 |
| 2022 | $576 |
| 2021 | $589 |
| 2020 | $517 |
| 2019 | $480 |
| 2018 | $992 |
| 2017 | $846 |
| 2016 | $685 |
| 2015 | $557 |
| 2014 | $390 |
| 2013 | $19 |
| 2012 | $-139 |
| 2011 | $-56 |
| 2010 | $-60 |
| 2009 | $-76 |
| Enovis Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-09-30 | $420 |
| 2024-06-30 | $452 |
| 2024-03-31 | $470 |
| 2023-12-31 | $542 |
| 2023-09-30 | $540 |
| 2023-06-30 | $542 |
| 2023-03-31 | $552 |
| 2022-12-31 | $576 |
| 2022-09-30 | $614 |
| 2022-06-30 | $681 |
| 2022-03-31 | $604 |
| 2021-12-31 | $589 |
| 2021-09-30 | $591 |
| 2021-06-30 | $565 |
| 2021-03-31 | $536 |
| 2020-12-31 | $517 |
| 2020-09-30 | $484 |
| 2020-06-30 | $471 |
| 2020-03-31 | $479 |
| 2019-12-31 | $480 |
| 2019-09-30 | $496 |
| 2019-06-30 | $486 |
| 2019-03-31 | $955 |
| 2018-12-31 | $992 |
| 2018-09-30 | $946 |
| 2018-06-30 | $915 |
| 2018-03-31 | $876 |
| 2017-12-31 | $846 |
| 2017-09-30 | $833 |
| 2017-06-30 | $787 |
| 2017-03-31 | $734 |
| 2016-12-31 | $685 |
| 2016-09-30 | $648 |
| 2016-06-30 | $620 |
| 2016-03-31 | $580 |
| 2015-12-31 | $557 |
| 2015-09-30 | $513 |
| 2015-06-30 | $495 |
| 2015-03-31 | $442 |
| 2014-12-31 | $390 |
| 2014-09-30 | $309 |
| 2014-06-30 | $236 |
| 2014-03-31 | $44 |
| 2013-12-31 | $19 |
| 2013-09-30 | $-13 |
| 2013-06-30 | $-63 |
| 2013-03-31 | $-116 |
| 2012-12-31 | $-139 |
| 2012-09-30 | $-154 |
| 2012-06-30 | $-158 |
| 2012-03-31 | $-165 |
| 2011-12-31 | $-56 |
| 2011-09-30 | $-39 |
| 2011-06-30 | $-43 |
| 2011-03-31 | $-54 |
| 2010-12-31 | $-60 |
| 2010-09-30 | $-69 |
| 2010-06-30 | $-90 |
| 2010-03-31 | $-92 |
| 2009-12-31 | $-76 |
| 2009-09-30 | $-97 |
| 2009-06-30 | $-102 |
| 2009-03-31 | $-106 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.646B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.978B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.055B | 188.82 |
| Hims & Hers Health (HIMS) | United States | $5.988B | 154.89 |
| Axonics (AXNX) | United States | $3.602B | 1762.00 |
| IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
| Privia Health (PRVA) | United States | $2.736B | 228.00 |
| Omnicell (OMCL) | United States | $2.263B | 74.03 |
| Azenta (AZTA) | United States | $2.242B | 127.33 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
| Schrodinger (SDGR) | United States | $1.422B | 0.00 |
| Phreesia (PHR) | United States | $1.252B | 0.00 |
| Standard BioTools (LAB) | United States | $0.830B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
| Talkspace (TALK) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
| Health Catalyst (HCAT) | United States | $0.506B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| TruBridge (TBRG) | United States | $0.214B | 62.22 |
| P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.050B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| CareCloud (CCLD) | United States | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |